Strayer; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Strayer; David.The latest application filed is for "dsrnas as influenza virus vaccine adjuvants or immuno-stimulants".

Company Profile

0.8.16

Strayer; David - Bryn Mawr PA
Strayer; David - Phoenix AZ
Strayer; David - Byrn Mawr PA
Strayer; David - Salt Lake City UT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity Grant 9,315,538 - Carter , et al. April 19, 2	2016-04-19
Dsrnas As Influenza Virus Vaccine Adjuvants Or Immuno-stimulants App 20150064216 - CARTER; William A. ; et al.	2015-03-05
Bicycle rack and workstation Grant D661,623 - Strayer June 12, 2	2012-06-12
Bicycle rack and workstation Grant D660,749 - Strayer May 29, 2	2012-05-29
Treating Chronic Fatigue Syndrome And Prolonged Qt Interval App 20120004290 - Strayer; David ; et al.	2012-01-05
Broad spectrum immune and antiviral gene modulation by oral interferon Grant 8,075,878 - Carter , et al. December 13, 2	2011-12-13
dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants App 20110223198 - Carter; William A. ; et al.	2011-09-15
Treatment Of Chronic Fatigue Syndrome Using Selective Agonists Of Toll-like Receptor 3 (tlr3) App 20110196020 - Carter; William A. ; et al.	2011-08-11
dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants Grant 7,943,147 - Carter , et al. May 17, 2	2011-05-17
Genetec Regulation Of Host Defense Mechanisms By Mucosal Exposure To Natural Interferon Alpha Species App 20110044946 - Carter; William A. ; et al.	2011-02-24
Selective Agonist Of Toll-like Receptor 3 App 20100310600 - Carter; William A. ; et al.	2010-12-09
Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity App 20100160413 - Carter; William A. ; et al.	2010-06-24
Early Intervention Of Viral Infection With Immune Activators App 20100104533 - Carter; William A. ; et al.	2010-04-29
Anesthesia drug monitor Grant 7,693,697 - Westenskow , et al. April 6, 2	2010-04-06
Treating severe acute respiratory syndrome Grant 7,678,774 - Carter , et al. March 16, 2	2010-03-16
Method and apparatus for monitoring dynamic cardiovascular function using n-dimensional representatives of critical functions Grant 7,654,966 - Westinskow , et al. February 2, 2	2010-02-02
Treating severe and acute viral infections App 20090304630 - Carter; William A. ; et al.	2009-12-10
Broad spectrum immune and antiviral gene modulation by oral interferon App 20080019943 - Carter; William A. ; et al.	2008-01-24
dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants App 20070224219 - Carter; William A. ; et al.	2007-09-27
Treating severe acute respiratory syndrome App 20070141080 - Carter; William A. ; et al.	2007-06-21
Treating severe and acute viral infections App 20060035859 - Carter; William A. ; et al.	2006-02-16
Treating server acute respiratory syndrome App 20050137154 - Carter, William A. ; et al.	2005-06-23
Method and apparatus for monitoring dynamic cardiovascular function using n-dimensional representations of critical functions App 20030227472 - Westinskow, Dwayne ; et al.	2003-12-11
Anesthesia drug monitor App 20030156143 - Westenskow, Dwayne ; et al.	2003-08-21

Company Registrations

NCAGE Code	4R8S6	STRAYER, DAVID
NCAGE Code	3XGQ5	STRAYER DAVID!DBA STC SERVICES
CAGE Code	3XGQ5	STRAYER, DAVID STC SERVICES
CAGE Code	4R8S6	STRAYER, DAVID
DUNS	798237009	STRAYER, DAVID

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.